Lonza · 1 month ago
QA Specialist III-Lot Review
Lonza is a global leader in life sciences manufacturing, and they are seeking a QA Specialist III to ensure the integrity and compliance of their manufacturing processes. In this role, you will review manufacturing batch records, resolve issues, and collaborate with various teams to maintain compliance while contributing to the release of life-changing therapies.
BiotechnologyLife SciencePharmaceutical
Responsibilities
Review and close manufacturing batch records and related documentation for API release
Resolve issues and escalate complex cases when needed
Participate in daily lot release meetings and routine QA activities
Train junior staff on record review processes
Apply data integrity principles in all aspects of work
Support process improvement projects and quality initiatives
Collaborate with QA, QC, and Manufacturing teams to maintain compliance
Qualification
Required
Bachelor's degree in Science or related field
5–10 years of experience in cGMP environments
Strong knowledge of quality systems and good documentation practices
Excellent attention to detail and critical thinking skills
Effective written and verbal communication skills
Ability to work independently and within a team environment
Proficiency in Microsoft Office
Preferred
Experience with Trackwise and SAP
Benefits
Medical, dental, and vision insurance
Opportunities for professional growth and leadership development
Company
Lonza
Lonza Group supplies products and services to pharmaceutical and agrochemical industries.
H1B Sponsorship
Lonza has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2024 (3)
2022 (1)
2021 (3)
2020 (2)
Funding
Current Stage
Public CompanyTotal Funding
$444.8M2023-11-06Post Ipo Debt· $444.8M
2020-12-07IPO
Recent News
NH Business Review
2026-01-17
Company data provided by crunchbase